215 related articles for article (PubMed ID: 11279206)
41. Regulation of the PTEN phosphatase.
Gericke A; Munson M; Ross AH
Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
[TBL] [Abstract][Full Text] [Related]
42. Multiple inositol polyphosphate phosphatase: evolution as a distinct group within the histidine phosphatase family and chromosomal localization of the human and mouse genes to chromosomes 10q23 and 19.
Chi H; Tiller GE; Dasouki MJ; Romano PR; Wang J; O'keefe RJ; Puzas JE; Rosier RN; Reynolds PR
Genomics; 1999 Mar; 56(3):324-36. PubMed ID: 10087200
[TBL] [Abstract][Full Text] [Related]
43. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities.
Lopez SM; Hodgson MC; Packianathan C; Bingol-Ozakpinar O; Uras F; Rosen BP; Agoulnik IU
Biochem Biophys Res Commun; 2013 Oct; 440(2):277-82. PubMed ID: 24070612
[TBL] [Abstract][Full Text] [Related]
44. PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac.
Kim JS; Peng X; De PK; Geahlen RL; Durden DL
Blood; 2002 Jan; 99(2):694-7. PubMed ID: 11781256
[TBL] [Abstract][Full Text] [Related]
45. Alternative splicing of the Drosophila PTEN gene.
Smith A; Smith A; Alrubaie S; Coehlo C; Leevers SJ; Ashworth A
Biochim Biophys Acta; 1999 Oct; 1447(2-3):313-7. PubMed ID: 10542333
[TBL] [Abstract][Full Text] [Related]
46. A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine phosphatase and maps to the pericentromeric region of human chromosomes 21 and 13, and to chromosomes 15, 22, and Y.
Chen H; Rossier C; Morris MA; Scott HS; Gos A; Bairoch A; Antonarakis SE
Hum Genet; 1999 Nov; 105(5):399-409. PubMed ID: 10598804
[TBL] [Abstract][Full Text] [Related]
47. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways.
Gao X; Neufeld TP; Pan D
Dev Biol; 2000 May; 221(2):404-18. PubMed ID: 10790335
[TBL] [Abstract][Full Text] [Related]
48. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
49. A synaptojanin-homologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation.
Marcus SL; Wenk MR; Steele-Mortimer O; Finlay BB
FEBS Lett; 2001 Apr; 494(3):201-7. PubMed ID: 11311241
[TBL] [Abstract][Full Text] [Related]
50. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
51. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
[TBL] [Abstract][Full Text] [Related]
52. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
[TBL] [Abstract][Full Text] [Related]
53. Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9.
Mochizuki Y; Majerus PW
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9768-73. PubMed ID: 12890864
[TBL] [Abstract][Full Text] [Related]
54. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.
Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699
[TBL] [Abstract][Full Text] [Related]
55. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
Stambolic V; Suzuki A; de la Pompa JL; Brothers GM; Mirtsos C; Sasaki T; Ruland J; Penninger JM; Siderovski DP; Mak TW
Cell; 1998 Oct; 95(1):29-39. PubMed ID: 9778245
[TBL] [Abstract][Full Text] [Related]
56. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
Bianco R; Shin I; Ritter CA; Yakes FM; Basso A; Rosen N; Tsurutani J; Dennis PA; Mills GB; Arteaga CL
Oncogene; 2003 May; 22(18):2812-22. PubMed ID: 12743604
[TBL] [Abstract][Full Text] [Related]
57. Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.
Oganesian A; Poot M; Daum G; Coats SA; Wright MB; Seifert RA; Bowen-Pope DF
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7563-8. PubMed ID: 12802008
[TBL] [Abstract][Full Text] [Related]
58. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
Slack DN; Seternes OM; Gabrielsen M; Keyse SM
J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
[TBL] [Abstract][Full Text] [Related]
59. Structural assets of a tumor suppressor.
Tonks NK; Myers MP
Science; 1999 Dec; 286(5447):2096-7. PubMed ID: 10617421
[No Abstract] [Full Text] [Related]
60. Specificity determinants in phosphoinositide dephosphorylation: crystal structure of an archetypal inositol polyphosphate 5-phosphatase.
Tsujishita Y; Guo S; Stolz LE; York JD; Hurley JH
Cell; 2001 May; 105(3):379-89. PubMed ID: 11348594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
